Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS

Parkinsonism and Related Disorders

Volumn 19, Issue 1, 2013, Pages 15-20

  Ogaki, Kotaro ^a   Li, Yuanzhe ^a   Takanashi, Masashi ^a   Ishikawa, Kei Ichi ^a   Kobayashi, Tomonori ^b   Nonaka, Takashi ^c   Hasegawa, Masato ^c   Kishi, Masahiko ^d   Yoshino, Hiroyo ^a   Funayama, Manabu ^a   Tsukamoto, Tetsuro ^e   Shioya, Keiichi ^f   Yokochi, Masayuki ^g   Imai, Hisamasa ^a   Sasaki, Ryogen ^h   Kokubo, Yasumasa ^h   Kuzuhara, Shigeki ⁱ   Motoi, Yumiko ^a   Tomiyama, Hiroyuki ^a   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d TOHO UNIVERSITY   (Japan)

^e Department of Neurology   (Japan)

^f National Hospital Organization Miyazaki Higashi Hospital   (Japan)

^g Department of Dentistry Oral surgery   (Japan)

^h MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Abnormal eye movements; C9orf72; De novo; MAPT; PGRN

Indexed keywords

PROGRANULIN; TAU PROTEIN;

ADULT; ARTICLE; C9ORF72 GENE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; EYE MOVEMENT DISORDER; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENE DOSAGE; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; INDEL MUTATION; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MAPT GENE; MUTATIONAL ANALYSIS; NUCLEOTIDE REPEAT; ONSET AGE; PGRN GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

AMYOTROPHIC LATERAL SCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOSKELETAL PROTEINS; DEMENTIA; DNA MUTATIONAL ANALYSIS; EYE MOVEMENTS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; NEURODEGENERATIVE DISEASES; PEDIGREE; PROTEINS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 84871512745     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.06.019     Document Type: Article

References (31)

1. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
2. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
3. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
4. Dejesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
5. Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-Linked ALS-FTD. Neuron 2011, 72:257-268.
6. Boeve B.F., Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol 2008, 65:460-464.
7. Murray M.E., Dejesus-Hernandez M., Rutherford N.J., Baker M., Duara R., Graff-Radford N.R., et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 2011, 122:673-690.
8. Lindquist S., Duno M., Batbayli M., Puschmann A., Braendgaard H., Mardosiene S., et al. Corticobasal and ataxia syndromes widen the spectrumof C9ORF72 hexanucleotide expansion disease. Clin Genetics 2012 May 31, [Epub ahead of print].
9. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
10. Mesulam M.M. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982, 11:592-598.
11. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
12. Boeve B.F., Lang A.E., Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003, 54(Suppl. 5):S15-S19.
13. Baker M., Kwok J.B., Kucera S., Crook R., Farrer M., Houlden H., et al. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22. Ann Neurol 1997, 42:794-798.
14. Keyser R.J., Lombard D., Veikondis R., Carr J., Bardien S. Analysis of exon dosage using MLPA in South African Parkinson's disease patients. Neurogenetics 2010, 11:305-312.
15. Varani L., Hasegawa M., Spillantini M.G., Smith M.J., Murrell J.R., Ghetti B., et al. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A 1999, 96:8229-8234.
16. Kobayashi T., Ota S., Tanaka K., Ito Y., Hasegawa M., Umeda Y., et al. A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology. Ann Neurol 2003, 53:133-137.
17. Clark L.N., Poorkaj P., Wszolek Z., Geschwind D.H., Nasreddine Z.S., Miller B., et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 1998, 95:13103-13107.
18. Spillantini M.G., Yoshida H., Rizzini C., Lantos P.L., Khan N., Rossor M.N., et al. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol 2000, 48:939-943.
19. Ogaki K., Motoi Y., Li Y., Tomiyama H., Shimizu N., Takanashi M., et al. Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): a comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy. Mov Disord 2011, 26:561-563.
20. Ghika J., Tennis M., Growdon J., Hoffman E., Johnson K. Environment-driven responses in progressive supranuclear palsy. J Neurol Sci 1995, 130:104-111.
21. Ogaki K., Li Y., Atsuta N., Tomiyama H., Funayama M., Watanabe H., et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with ALS. Neurobiol Aging 2012 June 21, [Epub ahead of print].
22. Pierrot-Deseilligny C., Gautier J.C., Loron P. Acquired ocular motor apraxia due to bilateral frontoparietal infarcts. Ann Neurol 1988, 23:199-202.
23. Leigh R.J.Z.D. The neurology of eye movements 2006, Oxford University Press, New York, p. 512-21, 638-45. 4 ed.
24. Rohrer J.D., Paviour D., Vandrovcova J., Hodges J., de Silva R., Rossor M.N. Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome. Neurodegener Dis 2011, 8:149-152.
25. Williams D.R., Pittman A.M., Revesz T., Lees A.J., de Silva R. Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy. Mov Disord 2007, 22:895-897.
26. Morris H.R., Osaki Y., Holton J., Lees A.J., Wood N.W., Revesz T., et al. Tau exon 10 + 16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. Neurology 2003, 61:102-104.
27. Rossi G., Gasparoli E., Pasquali C., Di Fede G., Testa D., Albanese A., et al. Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Ann Neurol 2004, 55:448.
28. Ros R., Thobois S., Streichenberger N., Kopp N., Sanchez M.P., Perez M., et al. A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy. Arch Neurol 2005, 62:1444-1450.
29. Kim H.J., Jeon B.S., Yun J.Y., Seong M.W., Park S.S., Lee J.Y. Screening for MAPT and PGRN mutations in Korean patients with PSP/CBS/FTD. Parkinsonism Relat Disord 2010, 16:305-306.
30. Mesulam M.M. Primary progressive aphasia-a language-based dementia. N Engl J Med 2003, 349:1535-1542.
31. Imai Y., Hasegawa K. The revised hasegawa's dementia scale (HDS-R) - evaluation of its usefulness as a screening test for dementia. J Hong Kong Coll Psychiatr 1994, 4:20-24.